Tests a decision aid tool for choosing ways to put liver care into practice
Tests a decision aid for choosing strategies to improve care for cirrhosis and liver cancer.
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Pittsburgh, United StatesSee the site
- Trial code
- Registry title
- Project OASIS: Optimizing Approaches to Select Implementation Strategies
- Status
- Enrolling by invitation
- People taking part
- 8,020 people, planned
- Started
- 1 Feb 2024
- Expected to end
- 31 Oct 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- OASIS DA training
- Current DA Tool training
- Record updated
- 4 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for Veterans with cirrhosis (or its complications) treated at a participating VA medical center, and VA clinicians and staff who choose ways to improve care there.
- Age
- 18 Years and older
- Sex
- All sexes can join.
- Disease stage
- Cirrhosis or its complications, shown by two outpatient or one inpatient diagnosis codes.
- Earlier treatment
- Veterans must have had a visit at a participating VA medical center in the prior 18 months. Veterans after a transplant cannot join.
Main reasons for not taking part
- Veterans after a transplant
- Veterans with active hepatocellular carcinoma
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Veterans:
- Veterans with two outpatient or one inpatient codes for cirrhosis or its complications who had an encounter in the prior 18 months at a participating VA medical center; VA clinicians:
- Physicians, advance practice providers, nurses, leadership, and staff engaged with selecting and applying implementation strategies to improve care at a participating VA medical center
Who cannot take part
- Veterans post-transplant or with active hepatocellular carcinoma
Where in United States
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PAPittsburgh, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
Barriers that prevent healthcare methods supported by science from being adopted in the real world have led to low-quality, inequitable medical care. Implementation science aims to bridge the evidence-to-practice gap but still lacks simple and convenient methods to identify implementation barriers, systematically track which strategies work to improve care, and provide accessible data and expert recommendations to guide implementation strategy selection for use in research and practice. Project OASIS (Optimizing Approaches to Select Implementation Strategies) will conduct a hybrid type-III, cluster-randomized trial of a new decision aid tool that matches site variables and barriers to successful implementation strategies.
The 2 groups in the trial
- OASIS DATreatment being tested
Half of the sites will be randomized to receive training on the OASIS decision aid.
Treatment: OASIS DA training
- Current DA ToolExisting treatment, for comparison
Half of the sites will be randomized to receive training on the current decision aid tool.
Treatment: Current DA Tool training
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Project OASIS: Optimizing Approaches to Select Implementation Strategies
- Plain-language title
- Tests a decision aid tool for choosing ways to put liver care into practiceGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 4 February 2026